AzTrials
AzTrials

Analgesics, OpioidNCT06487988

Asleep Fiberoptic vs Direct Laryngoscopy Effect on Hemodynamic Stability Using Opioid Free Anesthesia Induction

A study testing direct conventional laryngoscopy and fiberoptic guided intubation in people with Analgesics, Opioid and Anesthesia, General, run by American University of Beirut Medical Center at 1 site in Lebanon.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare heart rate between the fiberoptic and direct oral intubation using opioid free anesthesia induction. Secondary objectives include comparing blood ressure, oxygen saturation, time needed for intubation and the incidence of postoperative sore throat, hoarseness, and upper… Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
What is being tested?
direct conventional laryngoscopy and fiberoptic guided intubation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
1 siteLebanon
Study dates
11 Sep 2024to 9 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • ASA (American Society of Anesthesiologists) physical status I and II
  • Range age of 18-55 years' old
  • Scheduled for elective surgery under general anesthesia.

Who cannot join

  • History of cardiovascular diseases.
  • History of lung disease.
  • Hypertensive patient (BP> 140/90)
  • Patient taking medications that affect blood pressure and heart rate
  • Morbid obesity (BMI >40)
  • Severe GERD
Show all 12Show fewer
  • Predicted difficult airway (Short TMD <6 cm, Upper li bite test grade III, Mallampati score
  • >III)
  • Neck instability
  • Patient planned to receive rapid sequence intubation
  • Patient refusal to participate
  • History of difficult intubation/ ventilation

Trial locations and contacts

1 site in 1 country.

Lebanon1 site
  • Christian Rouphael

    Beirut

Other trials in Lebanon

About this study

The goal of this clinical trial is to compare heart rate between the fiberoptic and direct oral intubation using opioid free anesthesia induction. Secondary objectives include comparing blood ressure, oxygen saturation, time needed for intubation and the incidence of postoperative sore throat, hoarseness, and upper airway trauma in adults aging between 18 to 55 years, scheduled for elective surgery under general anesthesia.

The main question it aims to answer is:

Does fiberoptic intubation cause less hemodynamic instability than direct oral intubation using opioid free anesthesia induction?

Read the detailed description

Background: Intubation has always been linked to a transient increase in blood pressure and heart rate that could be deleterious in elderly and hemodynamically unstable patients. Fiberoptic intubation, which is currently used for suspected difficult intubation, could cause less marked rise in blood pressure and heart rate. Furthermore, "opioid free anesthesia" has gained popularity lately to avoid opioid adverse effects ranging from respiratory depression, postoperative ileus, sedation, nausea, vomiting and urinary retention.

Specific aims: The primary objective of this study is to compare blood pressure and heart rate between the fiberoptic and direct oral intubation using opioid free anesthesia induction. Secondary objectives include comparing the time needed for intubation and the incidence of postoperative sore throat, hoarseness, and upper airway trauma.

Methods: In this prospective randomized clinical trial, 68 adults aging between 18 to 55 years, scheduled for elective surgery under general anesthesia, will be recruited over 1 year of work. Patients will be randomly allocated to 2 groups: The direct conventional laryngoscopy group performed with N3 (for females) or N4 (for males) Macintosh laryngoscope blade, and the fiberoptic guided intubation group.

Significance: Studies comparing hemodynamic stability using fiberoptic intubation versus direct oral intubation in opioid free anesthesia are limited. The present study will assess whether fiberoptic intubation causes less hemodynamic instability than direct oral intubation in opioid free anesthesia induction, which will benefit patients with normal airways.

Being tested
direct conventional laryngoscopy, fiberoptic guided intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • direct conventional laryngoscopyDevice

    direct conventional laryngoscopy will be performed with N3 (for females) or N4 (for males) Macintosh laryngoscope blade.

  • fiberoptic guided intubationDevice

    fiberoptic guided intubation will be performed.

Study groups in NCT06487988
Study groupRoleWhat they receive
The direct conventional laryngoscopy groupActive comparatorThe direct conventional laryngoscopy group will be performed with N3 (for females) or N4 (for males) Macintosh laryngoscope blade.
Receives: Device: direct conventional laryngoscopy
The fiberoptic guided intubation groupExperimentalThe fiberoptic guided intubation will be performed.
Receives: Device: fiberoptic guided intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart rate

    Heart rate (bpm)

    Measured: baseline and up to 5 mins upon intubation

Secondary outcomes (5)
  1. time needed for intubation

    time (between face mask removal and first ETCO2 reading in minutes)

    Measured: between face mask removal and first ETCO2 reading in minutes

  2. incidence of postoperative sore throat

    Sore throat pain (0-10)

    Measured: after 24 hrs

  3. incidence of upper airway trauma

    incidence of upper airway trauma (Yes or No)

    Measured: during intubation

  4. Blood pressure

    Blood pressure (mm Hg)

    Measured: baseline and up to 5 mins upon intubation

  5. Oxygen saturation

    Oxygen saturation (SpO2%)

    Measured: baseline and up to 5 mins upon intubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2024
  2. Study start11 Sep 2024
  3. Primary completion9 Jun 2026
  4. Study completion9 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
68 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06487988
Sponsor's protocol ID
BIO-2023-0271
Status last verified
Oct 2026
First submitted
28 Jun 2024
Last updated
8 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing direct conventional laryngoscopy and fiberoptic guided intubation in people with Analgesics, Opioid and Anesthesia, General, run by American University of Beirut Medical Center at 1 site in Lebanon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart rate (time frame: baseline and up to 5 mins upon intubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in